TY - JOUR
T1 - Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19
T2 - JACC Scientific Expert Panel
AU - Expert Panel From the ACC Cardiovascular Imaging Leadership Council
AU - Rudski, Lawrence
AU - Januzzi, James L
AU - Rigolin, Vera H
AU - Bohula, Erin A
AU - Blankstein, Ron
AU - Patel, Amit R
AU - Bucciarelli-Ducci, Chiara
AU - Vorovich, Esther
AU - Mukherjee, Monica
AU - Rao, Sunil V
AU - Beanlands, Rob
AU - Villines, Todd C
AU - Di Carli, Marcelo F
N1 - Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2020/9/15
Y1 - 2020/9/15
N2 - Standard evaluation and management of the patient with suspected or proven cardiovascular complications of coronavirus disease-2019 (COVID-19), the disease caused by severe acute respiratory syndrome related-coronavirus-2 (SARS-CoV-2), is challenging. Routine history, physical examination, laboratory testing, electrocardiography, and plain x-ray imaging may often suffice for such patients, but given overlap between COVID-19 and typical cardiovascular diagnoses such as heart failure and acute myocardial infarction, need frequently arises for advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with confirmed or suspected COVID-19 infection and possible cardiovascular involvement, including chest discomfort with electrocardiographic changes, acute hemodynamic instability, newly recognized left ventricular dysfunction, as well as imaging during the subacute/chronic phase of COVID-19. For each, the authors consider the role of biomarker testing to guide imaging decision-making, provide differential diagnostic considerations, and offer general suggestions regarding application of various advanced imaging techniques.
AB - Standard evaluation and management of the patient with suspected or proven cardiovascular complications of coronavirus disease-2019 (COVID-19), the disease caused by severe acute respiratory syndrome related-coronavirus-2 (SARS-CoV-2), is challenging. Routine history, physical examination, laboratory testing, electrocardiography, and plain x-ray imaging may often suffice for such patients, but given overlap between COVID-19 and typical cardiovascular diagnoses such as heart failure and acute myocardial infarction, need frequently arises for advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with confirmed or suspected COVID-19 infection and possible cardiovascular involvement, including chest discomfort with electrocardiographic changes, acute hemodynamic instability, newly recognized left ventricular dysfunction, as well as imaging during the subacute/chronic phase of COVID-19. For each, the authors consider the role of biomarker testing to guide imaging decision-making, provide differential diagnostic considerations, and offer general suggestions regarding application of various advanced imaging techniques.
U2 - 10.1016/j.jacc.2020.06.080
DO - 10.1016/j.jacc.2020.06.080
M3 - Review article (Academic Journal)
C2 - 32710927
SN - 0735-1097
VL - 76
SP - 1345
EP - 1357
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 11
ER -